Antibodies will be the main course of therapeutics, due largely for their capacity to communicate with unique ligand conformations as a way to elicit unique Organic responses. On the other hand, discovery of latest molecules binding specific epitopes is time consuming and challenging, specifically for conditions demanding a specific antibody-ligand